Diamond Pharma Services Announce a Brexit Package


Brexit Package and Considerations Leaflet The negotiation for the final Brexit agreement and a new working-relationship between the EU and the UK still has many twists and turns ahead. From a medical perspective, the European Medicines Agency and EU Commission have published their expectations on the assumption of a Hard-Brexit scenario. The purpose of their …




Continue reading

Linguamatics announces University of Pennsylvania Health System as latest Enterprise NLP client


I2E Natural Language Processing advances research and care delivery by mining clinical insights from unstructured patient data Cambridge, UK & Boston, USA – June 20th, 2017 – Market leading Natural Language Processing (NLP) text analytics provider Linguamatics today announced the implementation of the Linguamatics Health enterprise NLP platform, powered by I2E, at the University of …




Continue reading

New Therapeutics Forum


A number of companies based on the Science Park have employees who are members of the New Therapeutics Forum and they are welcome to attend the next meeting. It is open to all scientists researching new therapeutics in Cambridge and the local area. The next meeting will be hosted by the Babraham Institute on Thursday …




Continue reading

X-ray vision surgery


Augmented reality paves the way for the future of surgery The latest in a series of surgical innovations from product design and development firm Cambridge Consultants is exploring how augmented reality (AR) could transform surgery. The company is showcasing an example of how an augmented surgical system might lower the risk involved in operations – …




Continue reading

Diamond BioPharm Ltd respond to a recent EMA Brexit announcement


On 2nd May 2017 the EMA and European Commission published a notice alerting Marketing Authorisation Holders of centrally authorised medicines of their obligations in relation to Brexit.1 Although the final deal between the UK and the EU is unknown, the notice assumes a complete regulatory break between both parties as of 30th March 2019. According to this notice, …




Continue reading

Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy


Pilot study demonstrates FAIMS technology is able to detect patients inadequately prepped prior to colonoscopy with 100% sensitivity Owlstone Medical, a diagnostics company developing a breathalyzer for disease, today announced it has entered into collaboration with Mayo Clinic, the leading US non-profit medical practice, education, and medical research group. The company’s FAIMS technology is being …




Continue reading

Engineering the future


Tim Fell and Richard Hammond

New partnership set to transform the engineering of biology   Product design and development firm Cambridge Consultants is joining forces with innovative software company Synthace in an ambitious bid to unlock the full potential of biology to address many of the global challenges facing the world. The partnership is aimed at boosting adoption of a …




Continue reading